Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Bibliographic citation
-
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis ; volume:4 ; number:4 ; year:2019 ; pages:131-143
Inflammatory intestinal diseases ; 4, Heft 4 (2019), 131-143
- Creator
-
Suzuki, Yasuo
Watanabe, Mamoru
Matsui, Toshiyuki
Motoya, Satoshi
Hisamatsu, Tadakazu
Yuasa, Hirotoshi
Tabira, Junichi
Isogawa, Naoki
Tsuchiwata, Shinichi
Arai, Shoko
Hibi, Toshifumi
- DOI
-
10.1159/000502144
- URN
-
urn:nbn:de:101:1-2019101700170226522279
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Suzuki, Yasuo
- Watanabe, Mamoru
- Matsui, Toshiyuki
- Motoya, Satoshi
- Hisamatsu, Tadakazu
- Yuasa, Hirotoshi
- Tabira, Junichi
- Isogawa, Naoki
- Tsuchiwata, Shinichi
- Arai, Shoko
- Hibi, Toshifumi
Other Objects (12)
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
5 Jahre Tofacitinib bei Colitis ulcerosa
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
5 Jahre Tofacitinib bei Colitis ulcerosa
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
5 Jahre Tofacitinib bei Colitis ulcerosa
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials